Drug Watch

Latest News

Rezpegaldesleukin Receives Fast Track Designation for Moderate to Severe AD
Rezpegaldesleukin Receives Fast Track Designation for Moderate to Severe AD

February 10th 2025

Nektar Therapeutics’ investigational biologic targets the IL-2 receptor complex.

Topical Corticosteroids: Potency, Vehicles, and Best Practices
Topical Corticosteroids: Potency, Vehicles, and Best Practices

February 10th 2025

Bunick Highlights Efficacy and Safety of JAK Inhibitors
Bunick Highlights Efficacy and Safety of JAK Inhibitors

February 9th 2025

Delgocitinib Could Close Gap in Adolescent CHE Treatment
Delgocitinib Could Close Gap in Adolescent CHE Treatment

February 4th 2025

Anaptys and Vanda Announce Global Licensing Agreement of Imsidolimab for GPP
Anaptys and Vanda Announce Global Licensing Agreement of Imsidolimab for GPP

February 3rd 2025

Video Interviews
Podcasts
The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
The Cutaneous Connection

More News

© 2025 MJH Life Sciences

All rights reserved.